Form 4: Guardant Health's Chief Legal Officer Reports Stock Transactions

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports transactions involving common stock and restricted stock units.

Summary

• On March 1, 2025, John G. Saia, the Chief Legal Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock and performance-based restricted stock units.
• Saia acquired 5,686 shares of common stock through the vesting of performance-based restricted stock units and another 263 shares through the vesting of restricted stock units.
• He also disposed of 3,079 shares to cover tax withholding obligations related to the vesting of restricted stock units at a price of $42.55 per share.
• Following these transactions, Saia directly owns 37,571 shares of common stock.
• He also holds 11,376 performance-based restricted stock units and 527 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining 67% of the performance-based restricted stock units will vest over the following two years, with 33% vesting on January 1, 2026, and 34% vesting on January 1, 2027.

Industry Context

This is a routine disclosure of stock transactions by a company insider, as required by SEC regulations. It doesn't necessarily reflect a broader trend in the industry but provides transparency into the actions of key personnel.

Key Dates